SMPD1 and Alzheimer disease: As described in several previous studies28–30 showing changes in the peripheral immune system of AD patients or mice that contributed to neuroinflammation in the brain, we observed reduction of CD4+ T and Treg cells, and an increase of Th17 cells, in the spleen and blood of young AD mice exposed to high plasma ASM.